HEALIUS LIMITED — Director's Dealing 2014

Oct 8, 2014

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	PRIMARY HEALTH CARE LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of DirectorDate of last notice	Dr Edmund Gregory Thomas Bateman26 September 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interestNature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest.	As shownNot applicable
Date of change	8 October 2014
No. of securities held prior tochange	2,751,394Abtourk (Syd No.391) Pty Ltd17,917,245Idameneo (No. 122) Pty Ltd104,836Belinda Carwardine Bateman andEdmund Gregory Thomas Bateman132,854Belinda Carwardine Bateman 358,762 Dr Edmund Bateman21,265,091Ordinary shares
Class	Fully paid ordinary shares
Number acquired	Not applicable
Number disposed	2,344,911
Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation	$4.192 per share

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held afterchange	406,483Abtourk (Syd No.391) Pty Ltd17,917,245Idameneo (No. 122) Pty Ltd104,836Belinda Carwardine Bateman andEdmund Gregory Thomas Bateman132,854Belinda Carwardine Bateman 358,762 Dr Edmund Bateman18,920,180Ordinary shares
Nature of changeExample:on-markettrade,off-markettrade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back	On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not applicable
Nature of interest	Not applicable
Name of registered holder(if issued securities)	Not applicable
Date of change	Not applicable
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract inrelation to which the interest has changed	Not applicable
Interest acquired	Not applicable
Interest disposed	Not applicable
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	Not applicable
Interest after change	Not applicable

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period where**prior written clearance was required? **	Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period?	Not applicable
If prior written clearance was provided, on what datewas this provided?	Not applicable

YD CACHIA Company Secretary Date: 9 October 2014

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011